These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1995272)

  • 1. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
    Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
    Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum.
    Biancone L; Fantini M; Tosti C; Bozzi R; Vavassori P; Pallone F
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):261-6. PubMed ID: 12610321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric protein loss as a marker of intestinal inflammatory activity in Crohn's disease: comparability of enteric clearance and stool concentration of alpha-1-antitrypsin?
    Hundegger K; Stufler M; Karbach U
    Z Gastroenterol; 1992 Oct; 30(10):722-8. PubMed ID: 1441675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces.
    van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A
    AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal alpha 1-antitrypsin as a measure of Crohn's disease activity. The effect of therapy and anatomical extent of disease.
    Meyers S; Lichtiger S; Feuer EJ; Lahman EA; Janowitz HD
    J Clin Gastroenterol; 1988 Oct; 10(5):491-7. PubMed ID: 3263408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K; Niederau C; Frieling T
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Consecutive Fecal Calprotectin Levels in the Perioperative Period and Its Predictive Capacity for Early Endoscopic Recurrence in Crohn's Disease.
    Liu R; Guo Z; Cao L; Wang Z; Gong J; Li Y; Zhu W
    Dis Colon Rectum; 2019 Mar; 62(3):318-326. PubMed ID: 30451756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
    Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
    J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
    Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
    J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive techniques for assessing postoperative recurrence in Crohn's disease.
    Biancone L; Onali S; Calabrese E; Petruzziello C; Zorzi F; Condino G; Sica GS; Pallone F
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S265-70. PubMed ID: 18598999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures.
    Lopes S; Andrade P; Rodrigues-Pinto E; Afonso J; Macedo G; Magro F
    World J Gastroenterol; 2017 Sep; 23(35):6482-6490. PubMed ID: 29085198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal loss and clearance of alpha-1-antitrypsin in children with persistent diarrhea.
    Duarte MA; Carneiro SM; Melo MC; Penna FJ
    Braz J Med Biol Res; 1994 Jul; 27(7):1553-60. PubMed ID: 7874022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.